Skip to main content
SpringerLink
Log in
Book cover

Diseases in the Homosexual Male pp 77–98Cite as

Hepatitis

  • Chapter

  • 66 Accesses

Part of the book series: The Bloomsbury Series in Clinical Science ((BLOOMSBURY))

Abstract

This chapter is largely devoted to hepatitis B virus infection, because of its high prevalence amongst homosexual men and the morbidity and mortality associated with the chronic carrier state, which develops in approximately 5% of those infected. There are three other main categories of viral hepatitis (Table 5.1).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Adler MW, Belsey EM, McCutchan JA, Mindel A (1983) Should homosexuals be vaccinated against hepatitis B virus? Cost and benefit assessment. Br Med J 286:1621–1624

    Article  CAS  Google Scholar 

  • Aldershville J, Dietrichson O, Skinhoj P, Kryger P, Mathiesen LR, Christoffersen P, Nielsen JO and the Copenhagen Hepatitis Acute Programme (1982) Chronic persistent hepatitis: serological classification and meaning of the hepatitis Be system. Hepatology 2:243–246.

    Article  Google Scholar 

  • Alexander GJM, Fagan EA, Guarner P et al. (1986a) A controlled trial of 6 months thrice weekly lym-phoblastoid interferon versus no therapy in chronic hepatitis B virus infection. J Hepatol 3 (suppl 2): S183–S188

    Article  PubMed  Google Scholar 

  • Alexander GJM, Fagan EA, Hegarty JE et al. (1986b) A controlled trial of acyclovir in stable chronic HBsAg, HBeAg positive carriers. J Hepatol 3 (suppl 2): S123–S127

    Article  PubMed  Google Scholar 

  • Alexander GJM, Brahm J, Fagan EA et al. (1987) Loss of HBsAg with interferon therapy in chronic hepatitis B virus infection. Lancet ii: 66–68

    Article  Google Scholar 

  • Amoroso P, Lettieri G, Giorgio A et al. (1986) Lack of correlation between fulminant form of viral hepatitis and retrovirus infection associated with the acquired immunodeficiency syndrome (AIDS) in drug addicts. Br Med J 292:376–377

    Article  CAS  Google Scholar 

  • Anderson MG, Harrison TJ, Alexander G, Zuckerman AJ, Murray-Lyon IM (1987) Randomised controlled trial of lymphoblastoid interferon for chronic active hepatitis B. Gut 28:619–622

    Article  PubMed  CAS  Google Scholar 

  • Barbara L, Mazzella G, Baraidini M et al. (1986) Randomised controlled trial with human lymphoblastoid interferon versus no treatment in chronic hepatitis B virus infection. J Hepatol 3 (suppl 2): S235–S238

    Article  PubMed  Google Scholar 

  • Biggar RJ, Goedert JJ, Hoofnagle J (1987) Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual males infected with HIV. N Engl J Med 316:630–631

    Article  PubMed  CAS  Google Scholar 

  • Blumberg BS, Alter HJ, Visnich S (1965) Anew antigen in leukaemia sera. JAMA 191:541–546

    Article  PubMed  CAS  Google Scholar 

  • Brechot C, Purcel C, Louise A, Rain B, Tiollais P (1980) Presence of integrated hepatitis B virus DNA sequences in cellular DNA of human hepatocellular carcinoma. Nature 286:533–535

    Article  PubMed  CAS  Google Scholar 

  • Brechot C, Hadchouel M, Scotto J et al. (1981) State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen positive and negative liver diseases. Proc Natl Acad Sci USA 78:3906–3910

    Article  PubMed  CAS  Google Scholar 

  • Burke CA (1986) A statistical view of clinical trials in chronic hepatitis B. J Hepatol 3 (suppl 2): S261–S267

    Article  PubMed  Google Scholar 

  • Carne CA, Weller IVD, Johnson AM et al. (1987a) Prevalence of antibodies to human immunodeficiency virus, gonorrhoea rates and changed sexual behaviour in homosexual men in London. Lancet i: 656–658

    Article  Google Scholar 

  • Carne CA, Weller IVD, Waite J et al. (1987b) Impaired responsiveness of homosexual men with HIV antibodies to plasma derived hepatitis B vaccine. Br Med J 294:866–868

    Article  CAS  Google Scholar 

  • Chadwick RG, Galizzi J, Heathcost J et al. (1979) Chronic persistent hepatitis: hepatitis B virus markers and histological follow-up. Gut 20: 372–377

    Article  PubMed  CAS  Google Scholar 

  • Chakraborty PR, Ruiz-opazo N, Shouval D, Shafritz DA (1980) Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg producing human hepatocellular carcinoma cell line. Nature 286:531–533

    Article  PubMed  CAS  Google Scholar 

  • Chalmers TC, Eckhardt RD, Reynolds WE et al. (1955) The treatment of acute infectious hepatitis. Controlled studies on the effects of diet, rest and physical reconditioning on the acute course of the disease and on the incidence of relapses and residual abnormalities. J Clin Invest 34:1163–1235

    Article  PubMed  CAS  Google Scholar 

  • Christenson B, Brostrom CH, Bottiger M et al. (1982) An epidemic outbreak of hepatitis A among homosexual men in Stockholm. Hepatitis A, a special hazard for the male homosexual subpopulation in Sweden. J Epidemiol 116:599–607

    CAS  Google Scholar 

  • Corey L, Holmes KK (1980) Sexual transmission of hepatitis A in homosexual men. Incidence and mechanism. N Engl J Med 302:435–438

    Article  PubMed  CAS  Google Scholar 

  • Coutinho RA, Albrecht-van lent P, Lelie N, Nagelkerke N, Kuipers H, Rijsdijk T (1983) Prevalence and incidence of hepatitis A among male homosexuals. Br Med J 287:1743–1745

    Article  CAS  Google Scholar 

  • Dane DS, Cameron CH, Briggs M (1970) Virus like particles in serum of patients with Australia antigen associated hepatitis. Lancet i: 695–698

    Article  Google Scholar 

  • Eddieston ALWF, Mandelli M, Mieli-Vergani G, Williams R (1982) Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. Hepatology 2:122S–127S

    Google Scholar 

  • Edman JC, Gray P, Valenzuela P, Rail LB, Rutter WJ (1980) Integration of hepatitis B virus sequences and their expression in a human hepatoma cell. Nature 286:535–538

    Article  PubMed  CAS  Google Scholar 

  • Fagan EA, Williams R (1986) Serological responses to HBV infection. Gut 27:858–867

    Article  PubMed  CAS  Google Scholar 

  • Fischl MA, Richman DD, Grieco MH et al. (1987) The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo controlled trial. N Engl J Med 317:185–191

    Article  PubMed  CAS  Google Scholar 

  • Francis DP, Hadler SC, Thompson SE et al. (1982) The prevention of hepatitis B with vaccine. Report of the Centers for Disease Control multi-center efficacy trial among homosexual men. Ann Intern Med 97: 362–366

    PubMed  CAS  Google Scholar 

  • Grady GF, Lee VA, Prince AM et al. (1978) Hepatitis B immune globulin for accidental exposures among medical personnel: final report of a multicenter controlled trial. J Infect Dis 138:625–638

    Article  PubMed  CAS  Google Scholar 

  • Harville DD, Summerskill WHJ (1963) Surgery in acute hepatitis. J Am Med Assoc 184:257–261

    Article  CAS  Google Scholar 

  • Heathcote J, Sherlock S (1973) Spread of acute type B hepatitis in London. Lancet i: 1468–1470

    Article  Google Scholar 

  • Hoofnagle JH (1980) Hepatitis B surface antigen (HBsAg) and antibody (anti-HBs). In: Bianchi L, Gerok W, Sickinger K, Stalder GA (eds) Virus and the liver. MTP Press Limited, pp 27–37

    Google Scholar 

  • Hoofnagle J (1986) Clinical trials of the interferons. J Hepatol 3 (suppl 2): S253–S258

    Google Scholar 

  • Hoofnagle JH, Seef LB, Bales B et al. (1979) Passive-active immunity from hepatitis B immune globulin re-analysis of a Veterans Administration Group study of needlestick hepatitis. Ann Intern Med 91: 813–818

    PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Minuk GY, Dusheiko GM et al. (1982) Adenine arabinoside 5’-monophosphate treatment of chronic type B hepatitis. Hepatology 2:784–788

    Article  PubMed  CAS  Google Scholar 

  • Hoofnagle JH, Mullen KD, Jones B et al. (1986) Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon-a preliminary report. N Engl J Med 315:1575–1578

    Article  PubMed  CAS  Google Scholar 

  • Iwarson SA (1987) Non-A, non-B hepatitis: dead ends or new horizons? Br Med J 295:946–948

    Article  CAS  Google Scholar 

  • Krogsgaard K, Lindhardt BO, Nielsen JO et al. (1987) The influence ofHTLV-III infection on the natural history of hepatitis B virus infection in male homosexual HBsAg carriers. Hepatology 1:37–41

    Article  Google Scholar 

  • Lai CL, Lok ASF, Lin HJ, Wu PC, Yeoh EU, Yeung CY (1987) Placebo controlled trial of recombinant alpha-2 interferon in Chinese HBsAg-carrier children. Lancet ii: 877–683

    Article  Google Scholar 

  • Lam KC, Lai CL, Ng RP, Trepo C, Wu PC (1981) Deleterious effect of prednisolone in HBsAg positive chronic active hepatitis. N Engl J Med 304:380–386

    Article  PubMed  CAS  Google Scholar 

  • Laure F, Chatenoud C, Pasquinelli C et al. (1987) Frequent lymphocyte infection by hepatitis B virus in haemophiliacs. Br J Haematol 65:181–185

    Article  PubMed  CAS  Google Scholar 

  • Liaw YF, Chu CM, Chen TJ, Lin DY, Chang-Chien CS, Wu CS (1982) Chronic lobular hepatitis: a clinicopathological and prognostic study. Hepatology 2:258–262

    Article  PubMed  CAS  Google Scholar 

  • Lok ASF, Weller IVD, Karayiannis P et al. (1984) Thrice weekly lymphoblastoid interferon is effective in inhibiting hepatitis B virus replication. Liver 4:45–49

    PubMed  CAS  Google Scholar 

  • Lok ASF, Lai CL, Wu PC (1986) Interferon therapy of chronic hepatitis B virus infection in Chinese. J Hepatol 3 (suppl 2): S209–S215

    Article  PubMed  Google Scholar 

  • Mackay P, Lees J, Murray K (1981) The conversion of hepatitis B core antigen synthesized in E. coli : into“e” antigen. J Med Virol 8:237–243

    Article  CAS  Google Scholar 

  • Magnius LO, Epsmark JA (1972) New specificities in Australia antigen positive sera distinct from the Le Bouvier determinants. J Immunol 109:1017–1021

    PubMed  CAS  Google Scholar 

  • McDonald JA, Caruso L, Karayiannis P et al. (1987a) Diminished responsiveness of male homosexual chronic hepatitis B virus carriers with HTLV-III antibodies to recombinant alpha-interferon. Hepatology 7: 719–723

    Article  PubMed  CAS  Google Scholar 

  • McDonald JA, Harris S, Waters JA, Thomas HC (1987b) Effect of human immunodeficiency virus (HIV) infection on chronic hepatitis B viral antigen display. J Hepatol 4:337–342

    Article  PubMed  CAS  Google Scholar 

  • Mindel A, Tedder RS (1981) Hepatitis A in homosexuals. Br Med J 282:1666

    Article  CAS  Google Scholar 

  • MRC and PHLS (Medical Research Council and Public Health Laboratory Service) (1980) The incidence of hepatitis B infection after accidental exposure and anti-HBs immunoglobulin prophylaxis. Lancet i: 6–8

    Google Scholar 

  • Mulley AG, Silverstein MD, Dienstag JC (1982) Indications for hepatitis B vaccine, based on cost effectiveness analysis. N Engl J Med 307:644–652

    Article  PubMed  CAS  Google Scholar 

  • Nielsen JO, Dietrichson O, Elling P, Christoggersen P (1971) Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med 285:1157–1160

    Article  PubMed  CAS  Google Scholar 

  • Noonan CA, Yoffe B, Mansell PW, Melnick JL, Hollinger FB (1986) Extxachromosomal sequences of hepatitis B virus DNA in peripheral blood mononuclear cells of acquired immune deficiency syndrome patients. Proc Natl Acad Sci USA 83:5698–5702

    Article  PubMed  CAS  Google Scholar 

  • Novick DM, Lok SF, Thomas HC (1985) Diminished responsiveness of homosexual men to antiviral therapy for HBsAg positive chronic liver disease. J Hepatol 1:15–27

    Article  Google Scholar 

  • Novick DM, Brown DJC, Lok ASF, Lloyd JC, Thomas HC (1986) Influence of sexual preference and chronic hepatitis B virus infection and T lymphocyte subsets, natural killer cell activity and suppressor cell activity. J Hepatol 3:363–370

    Article  PubMed  CAS  Google Scholar 

  • Omata M, Uchiumi K (1986) Combination of prednisolone withdrawal and antiviral agents (adenine, arabinoside, interferon) in chronic hepatitis B. J Hepatol 3 (suppl 2): S65–S69

    Article  PubMed  Google Scholar 

  • Pasquinelli C, Laure F, Chatenoud L (1986) Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and negative patients with acute and chronic liver disease. J Hepatol 3:95–103

    Article  PubMed  CAS  Google Scholar 

  • Perillo RP (1986) The use of corticosteroids in conjunction with antiviral therapy in chronic hepatitis B with ongoing viral replication. J Hepatol 3 (suppl 2); S57–S64

    Article  Google Scholar 

  • Perillo RP, Gelb L, Campbell C et al. (1979) Hepatitis BeAg, DNA polymerase activity and infection of household contacts with hepatitis B virus. Gastroenterology 76:1319–1325

    Google Scholar 

  • Perillo R, Regenstein F, Bodicky C et al. (1985) Comparative efficacy of adenine arabinoside 5’-monophosphate and prednisone withdrawal followed by adenine arabinoside 5’-monophosphate in the treatment of chronic active hepatitis B. Gastroenterology 88:780–786

    Google Scholar 

  • Perillo RP, Regenstein FG, Roodman ST (1986) Chronic hepatitis B in asymptomatic homosexual men with antibody to the human immunodeficiency virus. Ann Intern Med 105:382–383

    Google Scholar 

  • Pignatelli M, Waters J, Lever A, Iwarson S, Gerety R, Thomas HC (1987) Cytotoxic T-cell responses to the nucleocapsid proteins of HB V in chronic hepatitis-evidence that antibody modulation may cause protracted infection. J Hepatol 4:11–21

    Article  Google Scholar 

  • Prinsen H, Goilav C, Safary A, Andre FE, Piot P (1987) Immunogenicity and tolerance of a yeast derived hepatitis B vaccine in homosexual men. Postgrad Med J 63 (suppl 2): 147–150

    PubMed  Google Scholar 

  • Redeker AG, Mosley JW, Gocke DJ, McKee AP, Pollack W (1975) Hepatitis B immune globulin as a prophylactic measure for spouses exposed to acute type B hepatitis. N Engl J Med 293:1055–1059

    Article  PubMed  CAS  Google Scholar 

  • Reiner NE, Judson FN, Bond WW, Francis DP, Petersen NJ (1982) Asymptomatic rectal mucosal lesions and hepatitis B surface antigen at sites of sexual contact in homosexual men with persistent hepatitis B virus infection. Ann Intern Med 96:170–173

    PubMed  CAS  Google Scholar 

  • Repsher LH, Freebern RK (1969) Effect of exercise on recovery from infective hepatitis. N Engl J Med 281:1393–1396

    Article  PubMed  CAS  Google Scholar 

  • Rizzetto M, Verme G (1985) Delta hepatitis-present status. J Hepatol 1:187–193 Rizzetto M, Rosina F, Saracco G et al. (1986) Treatment of chronic delta hepatitis with alpha-2 recombinant interferon. J Hepatol 3 (suppl 2): S229–S233

    Google Scholar 

  • Schreeder MT, Thompson SE, Hadler SC et al. (1982) Hepatitis B in homosexual men: prevalence of infection and factors related to transmission. J Infect Dis 146:7–15

    Article  PubMed  CAS  Google Scholar 

  • Scott RM (1980) Experimental transmission of hepatitis B virus by semen and saliva. J Infect Dis 142: 67–71

    Article  PubMed  CAS  Google Scholar 

  • Scullard GA, Smith CI, Merigan TC, Robinson Ws, Gregory PB (1981a) Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B. Gastroenterology 81:987–991

    PubMed  CAS  Google Scholar 

  • Scullard GH, Pollard RB, Smith JI et al. (1981b) Antiviral treatment of chronic hepatitis B virus infection. Changes in viral markers with interferon combined with adenine arabinoside. J Infect Dis 143:772–783

    Article  PubMed  CAS  Google Scholar 

  • Summers J (1981) Three recently described animal virus models for human hepatitis B virus. Hepatology 1:179–183

    Article  PubMed  CAS  Google Scholar 

  • Summers J, Mason WS (1982) Properties of the hepatitis B like viruses related to their taxonomic classification. Hepatology 2: 61S–66S

    Google Scholar 

  • Swift WE, Gardner HT, Moore DJ, Streitfeld FH, Havens WP (1950) Clinical course of viral hepatitis and the effect of exercise during convalescence. Am J Med 8: 614–622

    Article  PubMed  Google Scholar 

  • Szmuness W (1978) Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol 24:40–69

    PubMed  CAS  Google Scholar 

  • Szmuness W, Stevens CE, Harley EJ et al. (1980) Hepatitis B vaccine. Demonstration of efficacy in a controlled clinical trial in a high risk population in the United States. N Engl J Med 303:833–841

    Article  PubMed  CAS  Google Scholar 

  • Tedder RS, Cameron CH, Wilson-Croome R, Howell DR, Colgrove A, Barbara JAJ (1980) Contrasting patterns and frequency of antibodies to the surface, core and e antigens of hepatitis B virus in blood donors and in homosexual patients. J Med Virol 6: 323–332

    Article  Google Scholar 

  • Teixeira MR Jr, Weiler IVD, Murray A et al. (1982) The pathology of hepatitis A in man. Liver 2:53–60

    PubMed  Google Scholar 

  • Thomas HC, Scully LJ, McDonald JA (1986) Lymphoblastom and recombinant alpha-A interferon therapy of chronic hepatitis B virus infection-the Royal Free Hospital experience. J Hepatol 3 (suppl 2): S193–S197

    Article  PubMed  Google Scholar 

  • Toillais P, Charnay P, Vyas GN (1981) Biology, hepatitis B virus. Science 213:406–411

    Article  Google Scholar 

  • Trepo C, Hartz O, Ouzan D (1984) Therapeutic efficacy of ARA-AMP in symptomatic HBeAg positive CAH: a randomised placebo controlled study. Hepatology 4:1055

    Google Scholar 

  • Underhill GS, Jeffries DJ, Forster GE, Harris JR (1986) Correlation between fulminant form of viral hepatitis and retrovirus infection associated with AIDS. Br Med J 292:1080–1081

    Article  CAS  Google Scholar 

  • Villa E, Rubbiani L, Barchi T et al. (1982) Susceptibility of chronic symptomless HBsAg carriers to ethanol-induced hepatic damage. Lancet ii: 1243–1244

    Article  Google Scholar 

  • Viola LA, Barrison IG, Coleman JC, Paradinas FJ, Fluker JL, Murray-Lyon IM (1981) Natural history of liver disease in chronic hepatitis B surface antigen carriers survey of 100 patients from Great Britain. Lancet ii: 1156–1159

    Google Scholar 

  • Viola LA, Barrison IG, Coleman JC, Murray-Lyon IM (1982) The clinical course of acute type A hepatitis in chronic HBsAg carriers-a report of 3 cases. Postgrad Med J 58: 80–81

    Article  PubMed  CAS  Google Scholar 

  • Ware AJ, Cuthbert JA, Shorey J, Gurian LE, Eigenbrodt EH, Combes B (1981) A prospective trial of steroid therapy in severe viral hepatitis. Gastroenterology 80:219–224

    PubMed  CAS  Google Scholar 

  • Weller IVD, Bassendine MF, Craxi A et al. (1982a) Successful treatment of HBs and HBeAg positive chronic liver disease: prolonged inhibition of viral replication by highly soluble adenine arabinoside 5’-monophosphate (ARA-AMP). Gut 23:717–723

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Bassendine MF, Murray A, Craxi A, Thomas HC, Sherlock S (1982b) Effects of pred-nisolone/azathioprine in chronic hepatitis B viral infection. Gut 23:650–655

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Fowler MJF, Monjardino J, Carreno V, Thomas HC, Sherlock S (1982c) Inhibition of hepatitis B viral replication by lymphoblastoid interferon. Philos Trans R Soc Lond (Biol) 299:128–130

    Article  CAS  Google Scholar 

  • Weller IVD, Carreno V, Fowler MJF et al. (1983a) Acyclovir in HBeAg-positive chronic liver disease. J Antimicrob Chemother 11:223–231

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Karayiannis P, Lok ASF et al. (1983b) The significance of delta agent infection in chronic hepatitis B virus infection: a study in British carriers. Gut 24:1016–1063

    Article  Google Scholar 

  • Weller IVD, Cohn D, Sierralta A et al. (1984) Clinical, biochemical, serological, histological and ultra-structural features of liver disease in drug abusers. Gut 25:417–423

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Lok ASF, Mindel A et al. (1985) Randomised controlled trial of adenine arabinoside 5’-monophosphate (ARA-AMP) in chronic hepatitis B virus infection. Gut 26:745–751

    Article  PubMed  CAS  Google Scholar 

  • Weller IVD, Brown A, Morgan B et al. (1986) Spontaneous loss of HBeAg and the prevalence of HTLV-III/LAV infection in a cohort of homosexual hepatitis B virus carriers and the implications for antiviral therapy. J Hepatol 3 (suppl 2): S9–S16

    Article  PubMed  Google Scholar 

Download references

Authors
  1. I. V. D. Weller
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Academic Department of Genito-Urinary Medicine, University College and Middlesex School of Medicine, James Pringle House, The Middlesex Hospital, W1N 8AA, London, UK

    Michael W. Adler MD, FRCP, FFCM (Professor of Genito-Urinary Medicine and Honorary Consultant, Physician) (Professor of Genito-Urinary Medicine and Honorary Consultant, Physician)

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Weller, I.V.D. (1988). Hepatitis. In: Adler, M.W. (eds) Diseases in the Homosexual Male. The Bloomsbury Series in Clinical Science. Springer, London. https://doi.org/10.1007/978-1-4471-1634-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-1634-9_5

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-1636-3

  • Online ISBN: 978-1-4471-1634-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation